Direct Oral Anticoagulants (DOAC) Testing
At the conclusion of this presentation the participants will be able to:
- Describe the role of the different DOACs (e.g., Rivaroxaban, Apixaban, Dabigatran)
- Describe the different anticoagulant effects of the DOACs
- Describe the laboratory methods used to measure DOACs and potential pitfalls
- Describe the pharmacokinetics of the different DOACs
Specially Curated for Laboratorians and offering PACE continuing education credits
- Anticoagulation DOACs TAVR (Transcatheter Aortic Valve Replacement) CVD (cardiovascular disease) Bleeding MCI (Myocardial Infarction) Hemostasis cardiovascular diseases coronary artery disease antiplatelet therapy testing and monitoring direct oral anticoagulants direct oral anticoagulants
- PACE
- CEU
- Continuing Ed
